The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, recently released a slideshow that emphasizes the notable scientific progress that NIAID researchers have accomplished for 2015.
Throughout the fiscal year, scientists and researchers from NIAID were based in national and international institutions. They were a significant part of the scientific progress in creating treatments and developing vaccines for influenza, HIV and Ebola. They also made progress in solving and preventing drug-resistant infections, like tuberculosis (TB), and various autoimmune diseases, allergies and illnesses.
Within the slideshow, NIAID displays 20 of its most significant achievements from 2015. All of these advances show that biomedical research is an important part of improving human health and making scientific progress.
One HIV study showed the importance of treating HIV early. Another made significant progress in using nanoparticle vaccine technology to create a universal flu vaccine. A third used Ebola samples to track the disease’s spread throughout West Africa. Further progress was made in estimating TB outcomes using medical imaging techniques, computed tomography, positron emission tomography and more.
These illnesses afflict countless people around the world, and solving these health concerns will benefit people around the globe.
